Hantavirüs İnfeksiyonları

Schmaljohn C, Hjelle B. Hantaviruses: a global disease problem. Emerging infectious diseases. 1997;3(2):95-104. doi:10.3201/eid0302.970202.

Jonsson CB, Figueiredo LT, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clinical microbiology reviews. 2010; 23(2): 412-41. doi:10.1128/CMR.00062-09

Lee HW, van der Groen G. Hemorrhagic fever with renal syndrome. Progress in medical virology. 1989;36:62-102.

Johnson KM. The discovery of hantaan virus: comparative biology and serendipity in a world at war. The Journal of infectious diseases. 2004;190(9): 1708-10.

Lee HW, Lee PW, Johnson KM. Isolation of the etiologic agent of Korean Hemorrhagic fever. The Journal of infectious diseases. 1978;137(3):298-308. doi: 10.1093/infdis/137.3.298.

Lee HW, Baek LJ, Johnson KM. Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats. The Journal of infectious diseases 1982;146:638.

Brummer-Korvenkontio M, Vaheri A, Hovi T, et al. Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection. The Journal of infectious diseases. 1980;141:131.

Avsic-Zupanc T, Xiao SY, Stojanovic R, et al. Characterization of Dobrava virus: a Hantavirus from Slovenia, Yugoslavia. Journal of medical virology. 1992; 38:132.

LeDuc JW, Smith GA, Johnson KM. Hantaan-like viruses from domestic rats captured in the United States. The American journal of tropical medicine and hygiene.1984; 33:992.

Lee PW, Goldgaber D, Gibbs CJ Jr, et al. Other serotypes of hemorrhagic fever with renal syndrome viruses in Europe. Lancet (London, England).1982; 2:1405.

Glass GE, Watson AJ, LeDuc JW, et al. Domestic cases of hemorrhagic fever with renal syndrome in the United States. Nephron. 1994; 68:48.

Vaheri A, Strandin T, Hepojoki J, et al. Uncovering the mysteries of hantavirus infections. Nature reviews. Microbiology. 2013;11(8):539-50. doi: 10.1038/nrmicro3066.

UpToDate. Epidemiology and diagnosis of hantavirus infections. (25/01/2023 tarihinde https://www.uptodate.com/contents/epidemiology-and-diagnosis-of-hantavirus-infections?search=hantavir%C3%BCs&source=search_result&selectedTitle=1~36&usage_type=default&display_rank=1#H1 adresinden ulaşılmıştır).

Mertz GJ, Hjelle BL, Bryan RT. Hantavirus infection. Advances in internal medicine. 1997; 42:369.

European Centre for Disease Prevention and Control. Hantavirus infection. (26/01/2023 tarihinde https://www.ecdc.europa.eu/sites/default/files/documents/AER-hantavirus-2019.pdf adresinden ulaşılmıştır).

Centers for Disease Control and Prevention. Reported Cases of Hantavirus Disease. (20/01/2023 tarihinde https://www.cdc.gov/hantavirus/surveillance/index.html adresinden ulaşılmıştır ).

Hjelle B, Glass GE. Outbreak of hantavirus infection in the Four Corners region of the United States in the wake of the 1997-1998 El Nino-southern oscillation. The Journal of infectious diseases. 2000; 181:1569. doi:10.1086/315467

Public Health Agency of Canada. Hantavirus pulmonary syndrome in Canada: An overview of clinical features, diagnostics, epidemiology and prevention. (25/01/2023 tarihinde http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/15vol41/dr-rm41-06/ar-02-eng.php adresinden ulaşılmıştır).

Matheus S, Kallel H, Mayence C, et al. Hantavirus Pulmonary Syndrome Caused by Maripa Virus in French Guiana, 2008-2016. Emerging infectious diseases. 2017; 23:1722. doi:10.3201/eid2310.170842

de Oliveira RC, Cordeiro-Santos M, Guterres A, et al. Rio Mamoré virus and hantavirus pulmonary syndrome, Brazil. Emerging infectious diseases. 2014;20:1568. doi:10.3201/eid2009.131472

Casapía M, Mamani E, García MP, et al. [Hantavirus pulmonary syndrome (Rio Mamore virus) in the Peruvian Amazon region]. Revista peruana de medicina experimental y salud publica. 2012; 29:390. doi:10.1590/s1726-46342012000300016

Haznedaroğlu T, Doğancı L, Gün H, et al. Türk Silahlı Kuvvetleri personelinde hantavirus sero-prevalansının “high density particle agglutination” yöntemiyle araştırılması. XXVI. Türk Mikrobiyoloji Kongresi, 11-15 Nisan 1994, Antalya, (1994).281.

Kavukçu S, Türkmen M, Salman Ş, et al. Ege Bölgesinde hantavirus ile ilişkili nefropati riski nedir? Türk Nefroloji Diyaliz ve Transplantasyon Dergisi. 1997; 6(3-4):131-5.

Çelebi G, Pişkin N, Öktem MA, et al. Bir salgının anatomisi. XIV. Türk Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi, 25-29 Mart 2009, Antalya, (2009).163.

Çelebi G. Hantavirus enfeksiyonları. Klinik Gelişim Dergisi. 2010; 23(3): 40-4.

Oktem MA, Ozkul A, Uyar Y. Seroprevalence of hantavirus infections among the rodent populations in Bartın, Turkey. The International Conference on Rodent Biology, 19-23 Haziran 2010, Zonguldak, (2010).128.

Uyar Y. Hantavirus enfeksiyonu laboratuvar tanısında Refik Saydam Hıfzıssıhha Merkezi Başkanlığı deneyimleri. Türk Hijyen ve Deneysel Biyoloji Dergisi. 2011; 68 (Suppl. 1): 51-6

T.C. Sağlık Bakanlığı Temel Sağlık Hizmetleri Genel Müdürlüğü Zoonotik Hastalıklar Daire Başkanlığı. Hantavirus enfeksiyonu, Ankara, 2020

Bi Z, Formenty PB, Roth CE. Hantavirus infection: a review and global update. Journal of infection in developing countries. 2008; 2(1): 3-23. doi:10.3855/jidc.317

Trencséni T, Keleti B. Clinical aspects and epidemiology of haemorrhagic fever with renal syndrome, Akadémai Kiadó, Budapest 1971.

Padula PJ, Edelstein A, Miguel SD, et al. Brote epidémico del síndrome pulmonar por Hantavirus en la Argentina. Evidencia molecular de la transmisión persona a persona del virus Andes [Epidemic outbreak of Hantavirus pulmonary syndrome in Argentina. Molecular evidence of person to person transmission of Andes virus]. Medicina (B Aires). 1998;58 Suppl 1:27-36. Spanish.

Fulhorst CF, Milazzo ML, Armstrong LR, et al. Hantavirus and arenavirus antibodies in persons with occupational rodent exposure. Emerging infectious diseases. 2007;13:532. doi: 10.3201/eid1304.061509.

Gardner SL, Von Essen S, Berger J, et al. Low seroprevalence among farmers from Nebraska and vicinity suggests low level of human exposure to sin nombre virus. Journal of agromedicine. 2005; 10:59. doi:10.1300/J096v10n01_09

Terajima M, Hendershot JD 3rd, Kariwa H, et al. High levels of viremia in patients with the Hantavirus pulmonary syndrome. The Journal of infectious diseases. 1999;180:2030. doi:10.1086/315153

Manigold T, Mori A, Graumann R, et al. Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by andes hantavirus. PLoS pathogens. 2010; 6:e1000779. doi:10.1371/journal.ppat.1000779

Mustonen J, Partanen J, Kanerva M, et al. Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scandinavian journal of immunology. 1998; 47:277. doi:10.1046/j.1365-3083.1998.00302.x

Vapalahti O, Lundkvist A, Vaheri A. Human immune response, host genetics, and severity of disease. Current topics in microbiology and immunology. 2001; 256:153. doi:10.1007/978-3-642-56753-7_9

Vaheri A, Vapalahti O, Plyusnin A. How to diagnose hantavirus infections and detect them in rodents and insectivores. Reviews in medical virology. 2008;18(4):277-88. doi:10.1002/rmv.581

Evander M, Eriksson I, Pettersson L. et al. Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. Journal of clinical microbiology. 2007;45(8): 2491-7. doi:10.1128/JCM.01902-06

Oktem IM, Uyar Y, Dincer E, et al. Dobrava-Belgrade virus in Apodemus flavicollis and A. uralensis mice, Turkey. Emerging infectious diseases. 2014;20(1):121-5. doi: 10.3201/eid2001.121024.

Zaki SR, Greer PW, Coffield LM, et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. The American journal of pathology. 1995; 146:552.

Green W, Feddersen R, Yousef O, et al. Tissue distribution of hantavirus antigen in naturally infected humans and deer mice. The Journal of infectious diseases. 1998; 177:1696. doi:10.1086/515325

Celebi G. Hantavirus İnfeksiyonları. Klimik Dergisi. 2011;24(3): 139-49

Sun Y, Chung DH, Chu YK, et al. Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5'-triphosphate, not with inhibition of IMP dehydrogenase. Antimicrobial agents and chemotherapy. 2007; 51:84. doi:10.1128/AAC.00790-06

Huggins JW, Hsiang CM, Cosgriff TM, et al. Prospective, doubleblind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. The Journal of infectious diseases. 1991; 164(6): 1119-27. doi:10.1093/infdis/164.6.1119

Rusnak JM, Byrne WR, Chung KN, et al. Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea. Antiviral research. 2009; 81(1): 68-76. doi:10.1016/j.antiviral.2008.09.007

Medina RA, Mirowsky-Garcia K, Hutt J, et al. Ribavirin, human convalescent plasma and anti-beta3 integrin antibody inhibit infection by Sin Nombre virus in the deer mouse model. The Journal of general virology. 2007; 88:493. doi:10.1099/vir.0.82459-0

Chapman LE, Mertz GJ, Peters CJ, et al. Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group. Antiviral Therapy. 1999; 4:211. doi:10.1177/135965359900400404

Mertz GJ, Miedzinski L, Goade D, et al. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clinical infectious diseases. 2004; 39:1307. doi:10.1086/425007

Medina RA, Mirowsky-Garcia K, Hutt J, et al. Ribavirin, human convalescent plasma and anti-beta3 integrin antibody inhibit infection by Sin Nombre virus in the deer mouse model. The Journal of general virology. 2007; 88:493. doi:10.1099/vir.0.82459-0

Sroga P, Sloan A, Warner BM, et al. Polyclonal alpaca antibodies protect against hantavirus pulmonary syndrome in a lethal Syrian hamster model. Scientific reports. 2021; 11:17440. doi:10.1038/s41598-021-96884-6

Williamson BN, Prescott J, Garrido JL, et al. Therapeutic Efficacy of Human Monoclonal Antibodies against Andes Virus Infection in Syrian Hamsters. Emerging infectious diseases. 2021; 27:2707. doi:10.3201/eid2710.210735

Duehr J, McMahon M, Williamson B, et al. Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model. mBio. 2020; 11. doi:10.1128/mBio.00028-20

Deng X, Tian S, Yu Z, et al. Development of small-molecule inhibitors against hantaviruses. Microbes and infection. 2020; 22:272. doi:10.1016/j.micinf.2020.05.011

Sanna G, Piras S, Madeddu S, et al. 5,6-Dichloro-2-phenyl-benzotriazoles: New Potent Inhibitors of Orthohantavirus. Viruses. 2020; 12. doi:10.3390/v12010122

Pettersson L, Klingström J, Hardestam J,et al. Hantavirus RNA in saliva from patients with hemorrhagic fever with renal syndrome. Emerging infectious diseases. 2008;14(3): 406-11. doi:10.3201/eid1403.071242

Hardestam J, Petterson L, Ahlm C, et al. Antiviral effect of human saliva against hantavirus. Journal of medical virology. 2008; 80(12): 2122-6. doi:10.1002/jmv.21332

Centers for Disease Control and Prevention. Hantavirus. (25/01/2023 tarihinde www.cdc.gov/ncidod/diseases/hanta/hps/ adresinden ulaşılmıştır).

Schmaljohn CS, Chu YK, Schmaljohn AL, Dalrymple JM. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. Journal of virology. 1990; 64:3162. doi:10.1128/JVI.64.7.3162-3170.1990

Xu X, Ruo SL, McCormick JB, Fisher-Hoch SP. Immunity to Hantavirus challenge in Meriones unguiculatus induced by vaccinia-vectored viral proteins. The American journal of tropical medicine and hygiene. 1992; 47:397. doi:10.4269/ajtmh.1992.47.397

Bharadwaj M, Nofchissey R, Goade D, et al. Humoral immune responses in the hantavirus cardiopulmonary syndrome. The Journal of infectious diseases. 2000; 182:43. doi:10.1086/315657

Vial PA, Valdivieso F, Calvo M, et al. A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome caused by Andes virus. Antiviral therapy. 2015; 20:377. doi:10.3851/IMP2875

Hooper JW, Larsen T, Custer DM, Schmaljohn CS. A lethal disease model for hantavirus pulmonary syndrome. Virology. 2001; 289:6. doi:10.1006/viro.2001.1133